192 related articles for article (PubMed ID: 17166484)
1. Sulfated cyclodextrins inhibit the entry of Plasmodium into red blood cells. Implications for malarial therapy.
Crandall IE; Szarek WA; Vlahakis JZ; Xu Y; Vohra R; Sui J; Kisilevsky R
Biochem Pharmacol; 2007 Mar; 73(5):632-42. PubMed ID: 17166484
[TBL] [Abstract][Full Text] [Related]
2. The anti-malarial activity of bivalent imidazolium salts.
Vlahakis JZ; Mitu S; Roman G; Patricia Rodriguez E; Crandall IE; Szarek WA
Bioorg Med Chem; 2011 Nov; 19(21):6525-42. PubMed ID: 21944972
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte G protein-coupled receptor signaling in malarial infection.
Harrison T; Samuel BU; Akompong T; Hamm H; Mohandas N; Lomasney JW; Haldar K
Science; 2003 Sep; 301(5640):1734-6. PubMed ID: 14500986
[TBL] [Abstract][Full Text] [Related]
4. Curcumin for malaria therapy.
Reddy RC; Vatsala PG; Keshamouni VG; Padmanaban G; Rangarajan PN
Biochem Biophys Res Commun; 2005 Jan; 326(2):472-4. PubMed ID: 15582601
[TBL] [Abstract][Full Text] [Related]
5. Role of calmodulin in Plasmodium falciparum: implications for erythrocyte invasion by the merozoite.
Matsumoto Y; Perry G; Scheibel LW; Aikawa M
Eur J Cell Biol; 1987 Dec; 45(1):36-43. PubMed ID: 3127214
[TBL] [Abstract][Full Text] [Related]
6. Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo.
Ghosh S; Chan JM; Lea CR; Meints GA; Lewis JC; Tovian ZS; Flessner RM; Loftus TC; Bruchhaus I; Kendrick H; Croft SL; Kemp RG; Kobayashi S; Nozaki T; Oldfield E
J Med Chem; 2004 Jan; 47(1):175-87. PubMed ID: 14695831
[TBL] [Abstract][Full Text] [Related]
7. Triterpenoids as inhibitors of erythrocytic and liver stages of Plasmodium infections.
Ramalhete C; da Cruz FP; Lopes D; Mulhovo S; Rosário VE; Prudêncio M; Ferreira MJ
Bioorg Med Chem; 2011 Dec; 19(24):7474-81. PubMed ID: 22071523
[TBL] [Abstract][Full Text] [Related]
8. Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships.
Mendoza A; Pérez-Silanes S; Quiliano M; Pabón A; Galiano S; González G; Garavito G; Zimic M; Vaisberg A; Aldana I; Monge A; Deharo E
Exp Parasitol; 2011 Jun; 128(2):97-103. PubMed ID: 21354139
[TBL] [Abstract][Full Text] [Related]
9. Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum.
Wilson DW; Goodman CD; Sleebs BE; Weiss GE; de Jong NW; Angrisano F; Langer C; Baum J; Crabb BS; Gilson PR; McFadden GI; Beeson JG
BMC Biol; 2015 Jul; 13():52. PubMed ID: 26187647
[TBL] [Abstract][Full Text] [Related]
10. Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.
Nallan L; Bauer KD; Bendale P; Rivas K; Yokoyama K; Hornéy CP; Pendyala PR; Floyd D; Lombardo LJ; Williams DK; Hamilton A; Sebti S; Windsor WT; Weber PC; Buckner FS; Chakrabarti D; Gelb MH; Van Voorhis WC
J Med Chem; 2005 Jun; 48(11):3704-13. PubMed ID: 15916422
[TBL] [Abstract][Full Text] [Related]
11. Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites.
Gilson PR; Crabb BS
Int J Parasitol; 2009 Jan; 39(1):91-6. PubMed ID: 18952091
[TBL] [Abstract][Full Text] [Related]
12. Import of host delta-aminolevulinate dehydratase into the malarial parasite: identification of a new drug target.
Bonday ZQ; Dhanasekaran S; Rangarajan PN; Padmanaban G
Nat Med; 2000 Aug; 6(8):898-903. PubMed ID: 10932227
[TBL] [Abstract][Full Text] [Related]
13. Screening and evaluation of inhibitors of Plasmodium falciparum merozoite egress and invasion using cytometry.
Bouillon A; Gorgette O; Mercereau-Puijalon O; Barale JC
Methods Mol Biol; 2013; 923():523-34. PubMed ID: 22990802
[TBL] [Abstract][Full Text] [Related]
14. Anti-Plasmodium activity of tetrazolium salts.
Cui X; Vlahakis JZ; Crandall IE; Szarek WA
Bioorg Med Chem; 2008 Feb; 16(4):1927-47. PubMed ID: 18078758
[TBL] [Abstract][Full Text] [Related]
15. Proteases in malaria-infected red blood cells.
Schrével J; Deguercy A; Mayer R; Monsigny M
Blood Cells; 1990; 16(2-3):563-84; discussion 585-90. PubMed ID: 2257326
[TBL] [Abstract][Full Text] [Related]
16. Effect of salinomycin-Na on malaria parasites (Plasmodium falciparum and P. berghei).
Mehlhorn H; Ganster HJ; Raether W
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar; 256(3):305-13. PubMed ID: 6375210
[TBL] [Abstract][Full Text] [Related]
17. Lead decreases parasitemia and enhances survival of Plasmodium berghei-infected mice.
Koka S; Huber SM; Boini KM; Lang C; Föller M; Lang F
Biochem Biophys Res Commun; 2007 Nov; 363(3):484-9. PubMed ID: 17888870
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
Snyder C; Chollet J; Santo-Tomas J; Scheurer C; Wittlin S
Exp Parasitol; 2007 Mar; 115(3):296-300. PubMed ID: 17087929
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial activity of crambescidin 800 and synthetic analogues against liver and blood stage of Plasmodium sp.
Lazaro JE; Nitcheu J; Mahmoudi N; Ibana JA; Mangalindan GC; Black GP; Howard-Jones AG; Moore CG; Thomas DA; Mazier D; Ireland CM; Concepcion GP; Murphy PJ; Diquet B
J Antibiot (Tokyo); 2006 Sep; 59(9):583-90. PubMed ID: 17136890
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium berghei: a new rat model for assessment of blood schizonticidal activity.
Dow GS; Reynoldson JA; Andrew Thompson RC
Exp Parasitol; 1999 Oct; 93(2):92-4. PubMed ID: 10502471
[No Abstract] [Full Text] [Related]
[Next] [New Search]
